Literature DB >> 11730229

Traumatic head injury in the anticoagulated elderly patient: a lethal combination.

A Karni1, R Holtzman, T Bass, G Zorman, L Carter, L Rodriguez, V J Bennett-Shipman, L Lottenberg.   

Abstract

Warfarin is the most common oral anticoagulant used for chronic anticoagulation therapy. Even without any antecedent trauma overanticoagulation can result in intracranial hemorrhage. The triad of anticoagulation with warfarin, age greater than 65 years, and traumatic head injury frequently produces a lethal brain hemorrhage. A retrospective review of more than 2000 patients admitted to the Trauma Service between September 1998 and May 2000 produced 278 patients with head injury and CT-documented intracranial hemorrhage. Of these patients 21 were admitted with an elevated prothrombin time (PT) due to anticoagulation with warfarin. Eighteen patients (86%) were above the age of 70. The most common indications for anticoagulation were atrial fibrillation (71%), deep venous thrombosis (19%), aortic valve replacement (9%), and ischemic cerebral infarcts (9%). Fourteen injuries were the result of a fall, one resulted from a gunshot wound, and one resulted from an assault. The remaining five patients were excluded as their history, workup, and evaluation by neurosurgery suggested a spontaneous bleed leading to fall rather than a fall causing a traumatic bleed. The average Glasgow Coma Score on admission was 11. The average PT and International Normalized Ratio (INR) on admission were 19.2 and 2.99 respectively. Eight of the 16 patients analyzed died. The risk of intracranial hemorrhage with relatively minor head injury is increased dramatically in the anticoagulated patient. A mortality rate of 50 per cent far exceeds the mortality rate in patients with similar head injuries who are not anticoagulated. In addition the risk/benefit equation of anticoagulation for the elderly is more complex and differs from that for younger patients. Perhaps more frequent and judicious monitoring of prothrombin time levels with lower therapeutic ranges (INR 1.5-2) is necessary.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730229

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  20 in total

1.  The costs of fatal and non-fatal falls among older adults.

Authors:  J A Stevens; P S Corso; E A Finkelstein; T R Miller
Journal:  Inj Prev       Date:  2006-10       Impact factor: 2.399

2.  Underutilization of Warfarin Therapy in Elderly Patients with Atrial Fibrillation - Fear or False Sense of Security!

Authors:  Mazda Biria; Ahmad Batrash; Jayasree Piallarisetti; James Vacek; Loren Berenbom; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

3.  Warfarin usage among elderly atrial fibrillation patients with traumatic injury, an analysis of United States Medicare fee-for-service enrollees.

Authors:  Xinggang Liu; Mona Baumgarten; Gordon Smith; Steven Gambert; Stephen Gottlieb; Gail Rattinger; Jennifer Albrecht; Patricia Langenberg; Ilene Zuckerman
Journal:  J Clin Pharmacol       Date:  2014-08-11       Impact factor: 3.126

Review 4.  Impact of age on the clinical outcomes of major trauma.

Authors:  F Hildebrand; H-C Pape; K Horst; H Andruszkow; P Kobbe; T-P Simon; G Marx; T Schürholz
Journal:  Eur J Trauma Emerg Surg       Date:  2015-08-08       Impact factor: 3.693

5.  Risk of unfavorable long-term outcome in older adults with traumatic intracranial hemorrhage and anticoagulant or antiplatelet use.

Authors:  Daniel K Nishijima; Kiarash Shahlaie; Korak Sarkar; Nancy Rudisill; James F Holmes
Journal:  Am J Emerg Med       Date:  2013-06-04       Impact factor: 2.469

6.  The epidemic of pre-injury oral antiplatelet and anticoagulant use.

Authors:  A E Berndtson; R Coimbra
Journal:  Eur J Trauma Emerg Surg       Date:  2014-05-01       Impact factor: 3.693

7.  Management of Patients with Acute Subdural Hemorrhage During Treatment with Direct Oral Anticoagulants.

Authors:  Christopher Beynon; Steffen Brenner; Alexander Younsi; Timolaos Rizos; Jan-Oliver Neumann; Johannes Pfaff; Andreas W Unterberg
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

8.  Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.

Authors:  Ryan M Rivosecchi; Joseph Durkin; David O Okonkwo; Bradley J Molyneaux
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

9.  Mild brain injury and anticoagulants: Less is enough.

Authors:  Laura Campiglio; Francesca Bianchi; Claudio Cattalini; Daniela Belvedere; Chiara Emilia Rosci; Chiara Livia Casellato; Manuela Secchi; Maria Cristina Saetti; Elena Baratelli; Alessandro Innocenti; Ilaria Cova; Chiara Gambini; Luca Romano; Gaia Oggioni; Rossella Pagani; Marco Gardinali; Alberto Priori
Journal:  Neurol Clin Pract       Date:  2017-08

Review 10.  Clinical review: Traumatic brain injury in patients receiving antiplatelet medication.

Authors:  Christopher Beynon; Daniel N Hertle; Andreas W Unterberg; Oliver W Sakowitz
Journal:  Crit Care       Date:  2012-07-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.